Zum Inhalt springen
· Dermal Fillers
SKU 10704

Lanluma V

In stock
Volume
210 mg/15 mL
Laboratory
Sinclair Pharma
Origin
Südkorea
Indication
Facial rejuvenation, fine lines and wrinkles, volume restoration in smaller targeted areas, neck and décolleté rejuvenation, hand and arm rejuvenation, abdominal and thigh skin laxity, cellulite, skin quality improvement
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.

Lanluma V is a poly-L-lactic acid (PLLA) collagen-stimulating injectable, manufactured by Sinclair Pharma in South Korea, positioned for smaller and more versatile treatment areas than its counterpart Lanluma X. As a Lanluma V filler, it works by stimulating the body's own collagen production for gradual, natural-looking rejuvenation of the face, neck and décolleté.

Key Benefits of Lanluma V

  • Stimulates natural collagen production
  • Improves skin quality and texture
  • Smooths fine lines and wrinkles
  • Provides subtle, natural-looking volume restoration
  • Long-lasting results (up to 2 years)
  • Suitable for smaller, targeted treatment areas
Key Information
Brand Lanluma
Manufacturer Sinclair Pharma
Country of Origin South Korea
Certification CE-marked Class III medical device (CE 1023)
Ingredients Per vial: poly-L-lactic acid (PLLA) 210 mg, CMC (sodium carboxymethyl cellulose), mannitol
Packaging 1 vial, 210 mg/15 mL, reconstituted before use
Use Type Professional use only - licensed medical practitioners
Injection Depth Dermis or subcutaneous layer; suprafascial on the hands
Protocol / Duration Gradual collagen-stimulation effect; results develop over 2-3 months and last up to 2 years

Indications and Professional Use

Main indications

  • Facial rejuvenation - fine lines, wrinkles and medium to deep folds
  • Volume restoration and contouring in smaller, targeted areas
  • Neck and décolleté rejuvenation
  • Skin quality, firmness and texture improvement
  • Hand rejuvenation
  • Upper arm skin laxity
  • Abdominal skin laxity and post-partum flaccidity (without hernia or diastasis)
  • Thighs and upper knees
  • Cellulite and skin dimpling
  • Correction of atrophy, lipoatrophy and post-surgical concerns

Professional use

For use by licensed medical professionals trained and authorised in PLLA injection only. Supplied as a sterile dry powder: 1 vial contains 210 mg poly-L-lactic acid. Reconstitute with 15 mL sterile water to obtain 14 mg/mL, shake the vial for 10 minutes, then let it stand for at least 1 hour to ensure complete hydration; agitate strongly for 1 minute immediately before use until a uniform translucent suspension is obtained. Double dilution gives 7 mg/mL and triple dilution 4.7 mg/mL; hyper-dilution is recommended for thin skin. 1 mL of 2% lidocaine may be added for patient comfort - account for the cumulative lidocaine dose. Administered subcutaneously by needle or cannula: typically a 21G cannula or 21-23G needle for the face, 22-23G for the neck, 23G for the décolleté, 21-22G for the hands (suprafascial on the hands), 21-23G for the arms and abdomen, 21G for the thighs and knees, and 18-23G for cellulite. Use 18-23G cannulas to limit clogging. Not to be used in or near the periorbital area, the lip or the eye contour; injection in the perioral region is contraindicated.

Treatment areas

  • Face - cheeks, chin, jawline, temples, nasolabial folds, areas of scarring
  • Neck
  • Décolleté
  • Hands
  • Upper arms
  • Abdomen
  • Thighs and upper knees
  • Cellulite-affected areas

Patient profile

Suitable for adult patients seeking gradual, natural-looking rejuvenation through collagen stimulation rather than immediate volumising - those with fine lines, mild to moderate volume loss, or reduced skin quality, firmness and density in the face, neck, décolleté, hands, arms, abdomen, thighs or knees. Contraindicated in patients with active inflammation or infection in or near the treatment area, or with hypersensitivity to any of the components; not to be used in or near the periorbital area and the lip, or in the eye contour.

How Lanluma V Works

Lanluma V is a poly-L-lactic acid (PLLA) powder that is reconstituted before use and injected subcutaneously by a trained medical professional.

Why Order From Allpara

Allpara offers genuine, verified LANLUMA products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.

Frequently Asked Questions

How does Lanluma V work?

Lanluma V is a poly-L-lactic acid (PLLA) powder, reconstituted before use and injected into the dermis or subcutaneous layer. Rather than adding volume instantly like a traditional filler, it stimulates the body's own collagen production, so results develop gradually over several weeks.

How does Lanluma V differ from Lanluma X?

Lanluma V is the smaller-vial presentation (210 mg, reconstituted with 15 mL sterile water), positioned for smaller and more versatile areas such as the face, neck, décolleté, hands, arms, abdomen, thighs and knees. Lanluma X is the larger-vial presentation (630 mg, reconstituted with 40 mL), positioned for larger body areas such as the buttocks.

/ Specifications

The datasheet

Category
Dermal Fillers
Brand
LANLUMA
Laboratory
Sinclair Pharma
SKU
10704
Format
210 mg/15 mL
Origin
Südkorea
Indication
Facial rejuvenation, fine lines and wrinkles, volume restoration in smaller targeted areas, neck and décolleté rejuvenation, hand and arm rejuvenation, abdominal and thigh skin laxity, cellulite, skin quality improvement
Use
Poly-L-lactic acid (PLLA) 210 mg powder reconstituted with 15 mL sterile water, injected subcutaneously by needle or 21-22G cannula by a licensed medical professional
/ Product details

The full file

Lanluma V is a poly-L-lactic acid (PLLA) collagen-stimulating injectable, manufactured by Sinclair Pharma in South Korea, positioned for smaller and more versatile treatment areas than its counterpart Lanluma X. As a Lanluma V filler, it works by stimulating the body's own collagen production for gradual, natural-looking rejuvenation of the face, neck and décolleté.

Sinclair Pharma, country of origin Südkorea.

Shipped EU-wide from our EU warehouse, tracked and insured, with 24-72h dispatch. Each unit ships with batch number and expiry, held in EU bond and batch-traceable.

Store to manufacturer specification, away from direct light. Cold-chain is only used where the product requires it.

Net 30 / 60 / 90 day terms* are available to verified accounts on credit approval. Invoicing is supported in EUR, CHF and GBP.

Terms are indicative and confirmed after account review.

How does Lanluma V work?

Lanluma V is a poly-L-lactic acid (PLLA) powder, reconstituted before use and injected into the dermis or subcutaneous layer. Rather than adding volume instantly like a traditional filler, it stimulates the body's own collagen production, so results develop gradually over several weeks.

How does Lanluma V differ from Lanluma X?

Lanluma V is the smaller-vial presentation (210 mg, reconstituted with 15 mL sterile water), positioned for smaller and more versatile areas such as the face, neck, décolleté, hands, arms, abdomen, thighs and knees. Lanluma X is the larger-vial presentation (630 mg, reconstituted with 40 mL), positioned for larger body areas such as the buttocks.

/ Quick answers

Everything a buyer asks first

How does Lanluma V work?
Lanluma V is a poly-L-lactic acid (PLLA) powder, reconstituted before use and injected into the dermis or subcutaneous layer. Rather than adding volume instantly like a traditional filler, it stimulates the body's own collagen production, so results develop gradually over several weeks.
How does Lanluma V differ from Lanluma X?
Lanluma V is the smaller-vial presentation (210 mg, reconstituted with 15 mL sterile water), positioned for smaller and more versatile areas such as the face, neck, décolleté, hands, arms, abdomen, thighs and knees. Lanluma X is the larger-vial presentation (630 mg, reconstituted with 40 mL), positioned for larger body areas such as the buttocks.
/ FAQ

Frequently asked

Lanluma V is a poly-L-lactic acid (PLLA) powder, reconstituted before use and injected into the dermis or subcutaneous layer. Rather than adding volume instantly like a traditional filler, it stimulates the body's own collagen production, so results develop gradually over several weeks.
Lanluma V is the smaller-vial presentation (210 mg, reconstituted with 15 mL sterile water), positioned for smaller and more versatile areas such as the face, neck, décolleté, hands, arms, abdomen, thighs and knees. Lanluma X is the larger-vial presentation (630 mg, reconstituted with 40 mL), positioned for larger body areas such as the buttocks.

More from Sinclair

View laboratory

Clinic alternatives

All products

Lanluma V

In stock
Verified-only pricing
Sign in or apply for a B2B account to see your price.
Apply for B2B

Lanluma V is a poly-L-lactic acid (PLLA) collagen-stimulating injectable, manufactured by Sinclair Pharma in South Korea, positioned for smaller and more versatile treatment areas than its counterpart Lanluma X. As a Lanluma V filler, it works by stimulating the body's own collagen production for gradual, natural-looking rejuvenation of the face, neck and décolleté.

Key Benefits of Lanluma V

  • Stimulates natural collagen production
  • Improves skin quality and texture
  • Smooths fine lines and wrinkles
  • Provides subtle, natural-looking volume restoration
  • Long-lasting results (up to 2 years)
  • Suitable for smaller, targeted treatment areas
Key Information
Brand Lanluma
Manufacturer Sinclair Pharma
Country of Origin South Korea
Certification CE-marked Class III medical device (CE 1023)
Ingredients Per vial: poly-L-lactic acid (PLLA) 210 mg, CMC (sodium carboxymethyl cellulose), mannitol
Packaging 1 vial, 210 mg/15 mL, reconstituted before use
Use Type Professional use only - licensed medical practitioners
Injection Depth Dermis or subcutaneous layer; suprafascial on the hands
Protocol / Duration Gradual collagen-stimulation effect; results develop over 2-3 months and last up to 2 years

Indications and Professional Use

Main indications

  • Facial rejuvenation - fine lines, wrinkles and medium to deep folds
  • Volume restoration and contouring in smaller, targeted areas
  • Neck and décolleté rejuvenation
  • Skin quality, firmness and texture improvement
  • Hand rejuvenation
  • Upper arm skin laxity
  • Abdominal skin laxity and post-partum flaccidity (without hernia or diastasis)
  • Thighs and upper knees
  • Cellulite and skin dimpling
  • Correction of atrophy, lipoatrophy and post-surgical concerns

Professional use

For use by licensed medical professionals trained and authorised in PLLA injection only. Supplied as a sterile dry powder: 1 vial contains 210 mg poly-L-lactic acid. Reconstitute with 15 mL sterile water to obtain 14 mg/mL, shake the vial for 10 minutes, then let it stand for at least 1 hour to ensure complete hydration; agitate strongly for 1 minute immediately before use until a uniform translucent suspension is obtained. Double dilution gives 7 mg/mL and triple dilution 4.7 mg/mL; hyper-dilution is recommended for thin skin. 1 mL of 2% lidocaine may be added for patient comfort - account for the cumulative lidocaine dose. Administered subcutaneously by needle or cannula: typically a 21G cannula or 21-23G needle for the face, 22-23G for the neck, 23G for the décolleté, 21-22G for the hands (suprafascial on the hands), 21-23G for the arms and abdomen, 21G for the thighs and knees, and 18-23G for cellulite. Use 18-23G cannulas to limit clogging. Not to be used in or near the periorbital area, the lip or the eye contour; injection in the perioral region is contraindicated.

Treatment areas

  • Face - cheeks, chin, jawline, temples, nasolabial folds, areas of scarring
  • Neck
  • Décolleté
  • Hands
  • Upper arms
  • Abdomen
  • Thighs and upper knees
  • Cellulite-affected areas

Patient profile

Suitable for adult patients seeking gradual, natural-looking rejuvenation through collagen stimulation rather than immediate volumising - those with fine lines, mild to moderate volume loss, or reduced skin quality, firmness and density in the face, neck, décolleté, hands, arms, abdomen, thighs or knees. Contraindicated in patients with active inflammation or infection in or near the treatment area, or with hypersensitivity to any of the components; not to be used in or near the periorbital area and the lip, or in the eye contour.

How Lanluma V Works

Lanluma V is a poly-L-lactic acid (PLLA) powder that is reconstituted before use and injected subcutaneously by a trained medical professional.

Why Order From Allpara

Allpara offers genuine, verified LANLUMA products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.

Frequently Asked Questions

How does Lanluma V work?

Lanluma V is a poly-L-lactic acid (PLLA) powder, reconstituted before use and injected into the dermis or subcutaneous layer. Rather than adding volume instantly like a traditional filler, it stimulates the body's own collagen production, so results develop gradually over several weeks.

How does Lanluma V differ from Lanluma X?

Lanluma V is the smaller-vial presentation (210 mg, reconstituted with 15 mL sterile water), positioned for smaller and more versatile areas such as the face, neck, décolleté, hands, arms, abdomen, thighs and knees. Lanluma X is the larger-vial presentation (630 mg, reconstituted with 40 mL), positioned for larger body areas such as the buttocks.

More from Sinclair

View laboratory →

Lanluma V is a poly-L-lactic acid (PLLA) collagen-stimulating injectable, manufactured by Sinclair Pharma in South Korea, positioned for smaller and more versatile treatment areas than its counterpart Lanluma X. As a Lanluma V filler, it works by stimulating the body's own collagen production for gradual, natural-looking rejuvenation of the face, neck and décolleté.

Sinclair Pharma, country of origin Südkorea.

Shipped EU-wide from our EU warehouse, 24-72h dispatch, tracked and insured. Each unit ships with batch number and expiry, held in EU bond and batch-traceable. Store to manufacturer specification.

Net 30 / 60 / 90 day terms* for verified accounts on credit approval. Invoicing in EUR, CHF and GBP.

How does Lanluma V work?

Lanluma V is a poly-L-lactic acid (PLLA) powder, reconstituted before use and injected into the dermis or subcutaneous layer. Rather than adding volume instantly like a traditional filler, it stimulates the body's own collagen production, so results develop gradually over several weeks.

How does Lanluma V differ from Lanluma X?

Lanluma V is the smaller-vial presentation (210 mg, reconstituted with 15 mL sterile water), positioned for smaller and more versatile areas such as the face, neck, décolleté, hands, arms, abdomen, thighs and knees. Lanluma X is the larger-vial presentation (630 mg, reconstituted with 40 mL), positioned for larger body areas such as the buttocks.

* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.